in patients with type ii diabetes , sulfonylurea therapy , which is associated with fewer adverse reactions than intensive insulin therapy , may lower the risk of atherosclerosis development by correcting hyperglycemia and associated lipid abnormalities .
C0021641
insulin
C0020456
hyperglycemia